Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 23 ... impact of opioid substitution treatment (OST) on opioid-dependent individuals with humanimmunodeficiencyvirus (HIV) infection is well documented, especially with regard to ... for all the analyses. Long-term virological success was defined as an undetectable viral load after at least 6 months on HAART. Retention in OST was defined as the time interval ...
2009 NOV 23 ... to a study from Durban, South Africa, "There is no validated case definition for humanimmunodeficiencyvirus-associated immune reconstitution inflammatory syndrome (IRIS). We ... Immunology, Infectious Diseases, Sexually Transmitted Disease, Therapy, Treatment, Viral, Virology, University of KwaZulu-Natal. This article was prepared by ... because 1 major criterion requires IRIS to be atypical and either an opportunistic infection or a tumor, although negative agreement was >98%. In contrast, CD2 had good positive ...
2009 NOV 23 ... characteristics, drug susceptibility test results, and risk factors, including humanimmunodeficiencyvirus (HIV) status, were compared for EPTB and PTB cases. Among 253,299 ... Center Diseases Control & Prevention, Division TB Eliminat, National Center HIV AIDS Viral Hepatitis Sexually Transm, 1600 Clifton Rd., Mailstop E-10, Atlanta, GA 30333, USA. ... USA. Keywords: City:Atlanta, State:GA, Country:United States, HIV/AIDS Co-Infection, AIDS, Acquired Immune Deficiency Syndrome, Acquired Immunodeficiency Syndrome, Bone, ...
2009 NOV 23 ... Technology, AIDS, Acquired Immunodeficiency Syndrome, Biochemistry, Biotechnology, HIV, HumanImmunodeficiencyVirus, Immunology, Public Health, Vaccines, Virology, ... new findings could help provide clues as how to interrupt the process of intercellular viral spread. (PLoS Pathogens, 6 November 2009) As many of us have learned from ... basic aspects of person-to-person transmission and of the progressive intercellular infection that depletes the immune system of its vital T cells remain imperfectly understood. In a ...
2009 NOV 23 ... into the clinical pipeline new agents to boost the power of vaccines to improve human health," said Dr. Iadonato. Dr. Gale concurred, "More effective and ... address key viral infections, including infections from the influenza viruses and human immunodeficiencyvirus (HIV). In addition, there is an important need to develop novel adjuvants to ... virus, influenza virus, and now HIV, trigger and control innate immune defenses during infection. Dr. Gale's research team has been credited with identifying the RIG-I pathway as a key ...
2009 NOV 23 ... According to recent research published in the journal Clinical Infectious Diseases, "Humanimmunodeficiencyvirus (HIV)-associated tuberculosis is difficult to treat, given the ... Inhibitor, Rifabutin, Ritonavir, Sexually Transmitted Disease, Therapy, Treatment, Viral, Virology, University of Florida. This article was prepared by ... the addition of lopinavir-ritonavir." "We analyzed 10 patients with HIV infection and active tuberculosis in a state tuberculosis hospital. Plasma was collected for ...
2009 NOV 23 ... research published in the journal Neurotoxicity Research, "The Tat protein of the humanimmunodeficiencyvirus (HIV) has been implicated in the pathophysiology of the ... HIV, Human Immunodeficiency Virus, Immunology, Neurology, Sexually Transmitted Disease, Viral, Virology. This article was prepared by AIDS Weekly editors from staff and ... implicated in the pathophysiology of the neurocognitive deficits associated with HIV infection. This is the earliest protein to be produced by the proviral DNA in the infected cell." ...
2009 NOV 23 ... "The introduction of 2 or 3 fully active drugs in humanimmunodeficiencyvirus (HIV)-infected patients receiving failing antiretroviral therapy ... Proteomics, Raltegravir, Ritonavir, Sexually Transmitted Disease, Therapy, Treatment, Viral, ViroLogic Inc., Virology. This article was prepared by Anti-Infectives ... Y. Yazdanpanah, Center Hospital Tourcoing, Faculty Med Lille, Service University Malad Infection & Voyageur, 135 Rue President Coty, BP 619, F-59208 Tourcoing, France. The ...
2009 NOV 24 ... age worldwide, and these deaths primarily occur in developing countries. Infection with humanimmunodeficiencyvirus (HIV) is also common among young children in many developing ... Immunodeficiency Virus, Acquired Immunodeficiency Syndrome, Vaccines, Rotavirus Vaccine, Viral, Biotechnology, Pediatric Vaccines. This article was prepared by Health ...
2009 NOV 23 ... CD4(+) T cells during the cognate T-cell and DC interaction. We report that HIV induces human genital mucosal epithelial cells to produce thymic stromal lymphopoietin (TSLP) via ... Sciences of the United States of America (TSLP production by epithelial cells exposed to immunodeficiencyvirus triggers DC-mediated mucosal infection of CD4(+) T cells. Proceedings of the ... we observed dramatic increases in TSLP expression concurrent with an increase in viral replication in the vaginal tissues within the first 2 weeks after vaginal SIV exposure. ...
2009 NOV 23 ... According to recent research from the United States, "Humanimmunodeficiencyvirus-1 (HIV-1) infection may produce neurological deficits, such as ... Immunology, Medical Device, Mental Health, Neuroscience, Sexually Transmitted Disease, Viral, Virology, Withdrawal Syndrome, University of Kentucky. This article was ...
2009 NOV 23 ... "In countries with both TB and humanimmunodeficiencyvirus (HIV) epidemics, HIV is known to be the most powerful risk factor ... Diseases, Mycobacteria, Mycobacterium Tuberculosis, Sexually Transmitted Disease, Viral, Virology, Centers for Disease Control and Prevention. This article was ... Keywords: City:Beijing, Country:People's Republic of China, HIV/AIDS Co-Infection, AIDS, Acquired Immune Deficiency Syndrome, Acquired Immunodeficiency Syndrome, ...
2009 NOV 28 ... Proceedings of the National Academy of Sciences.Alam, a member of the Duke Human Vaccine Institute and study senior author Bing Chen, Ph.D., assistant professor of ... are now ongoing in animals."Keywords: Pediatrics, AIDS, Acquired Immunodeficiency Syndrome, Biotechnology, HIV, Human ImmunodeficiencyVirus, Pediatrics, Vaccines, Viral, ... exposed to the antibodies for just a few minutes during the process of cell fusion and infection.But the problem for infection control is that such powerful antibodies are ...
2009 NOV 29 ... HIV/AIDS, AIDS, Acquired Immunodeficiency Syndrome, HIV, HumanImmunodeficiencyVirus, Magnetic Resonance, Structural Biology, Virology, University of ... that these seams provide the flexibility to dismantle the coat efficiently after viral entry into the host and to put it back together when new viruses emerge from the ... Those findings, reported in Cell, could point the way to new treatments for blocking HIV infection.The researchers used a combination of nuclear magnetic resonance and cryoEM, ...
Subject: University of Pittsburgh Schools of the Health Sciences
2009 NOV 23 ... "Because of the improvement in survival rates of humanimmunodeficiencyvirus (HIV)-infected patients after the introduction of combined ... Hypertension, Immunology, Pulmonology, Sexually Transmitted Disease, Therapy, Treatment, Viral, Virology. This article was prepared by Anti-Infectives Week editors from ... will be diagnosed more frequently and earlier in the course of the disease and HIV infection," scientists in the United States report. "The etiopathogenesis is not ...
2009 NOV 23 ... Antiviral, Clinical Trial Research, Drug Development, Drugs, Enzymes, Etravirine, HIV, HumanImmunodeficiencyVirus, Nonnucleoside Reverse Transcriptase Inhibitor, Pharmaceuticals, ... Transcriptase Inhibitor, Pharmaceuticals, Proteins, Proteomics, Therapy, Treatment, Viral Inhibition, Viral Therapy, Virology. This article was prepared by AIDS ... in genotypic tests for treatment-naive patients with documented recent (<1 year) infection, who had acquired HIV before the introduction of NNRTIs, were almost identical (9.8%, ...
